A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Saved in:
| Title: | A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Kim, Stephanie I.1 (AUTHOR), Szeto, Andy H.1 (AUTHOR), Morgan, Katherine P.2,3 (AUTHOR), Brower, Blaine4 (AUTHOR), Dunn, Mary W.4 (AUTHOR), Khandani, Amir H.5,6 (AUTHOR), Godley, Paul A.4,6 (AUTHOR), Rose, Tracy L.4,6 (AUTHOR), Basch, Ethan M.4,6 (AUTHOR), Milowsky, Matthew I.4,6 (AUTHOR), Whang, Young E.4,6 (AUTHOR) daniel.crona@unc.edu, Crona, Daniel J.1,3,6 (AUTHOR) daniel.crona@unc.edu |
| Source: | PLoS ONE. 6/21/2021, Vol. 16 Issue 6, p1-15. 15p. |
| Database: | Academic Search Ultimate |
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0253021 |
